| | | Single nucleotide variant (missense variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 | |
| | | Single nucleotide variant (missense variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 | |
| | | Single nucleotide variant (missense variant) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | not provided | |
| | | Single nucleotide variant (intron variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Epilepsy, idiopathic generalized, susceptibility to, 11 +1 more | |
| | | Single nucleotide variant (missense variant) | Leukoencephalopathy with mild cerebellar ataxia and white matter edema +3 more | |
| | | Single nucleotide variant (intron variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 +3 more | |
| | | Single nucleotide variant (intron variant) | not provided +3 more | |
| | | Single nucleotide variant (intron variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 +3 more | |
| | | Single nucleotide variant (intron variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 +3 more | |
| | | Single nucleotide variant (synonymous variant) | Familial hyperaldosteronism type II +3 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 +3 more | |
| | | Single nucleotide variant (missense variant) | Familial hyperaldosteronism type II +4 more | |
| | | Single nucleotide variant (missense variant) | Familial hyperaldosteronism type II +3 more | |
| | | Single nucleotide variant (missense variant) | Familial hyperaldosteronism type II +3 more | |
| | | Single nucleotide variant (missense variant) | Leukoencephalopathy with mild cerebellar ataxia and white matter edema +4 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 +2 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 +4 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Epilepsy, idiopathic generalized, susceptibility to, 11 +3 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 | |
| | | Deletion (frameshift variant) | not provided +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Leukoencephalopathy with mild cerebellar ataxia and white matter edema +4 more | |
| | | Single nucleotide variant (splice donor variant) | Familial hyperaldosteronism type II +3 more | |
| | | Single nucleotide variant (missense variant) | Leukoencephalopathy with mild cerebellar ataxia and white matter edema +3 more | |
| | | Single nucleotide variant (missense variant) | not provided +5 more | |
| | | Single nucleotide variant (intron variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 +3 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 +3 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +3 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +3 more | |
| | | Single nucleotide variant (intron variant) | not provided +3 more | |
| | | Single nucleotide variant (intron variant) | not provided +3 more | |
| | | Single nucleotide variant (synonymous variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 +3 more | |
| | | Single nucleotide variant (intron variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 +3 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 | |
| | | Single nucleotide variant (intron variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 +3 more | |
| | | Single nucleotide variant (missense variant) | Familial hyperaldosteronism type II +2 more | |
| | | Duplication (intron variant) | Epilepsy, idiopathic generalized, susceptibility to, 11 +3 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Single nucleotide variant (nonsense) | CLCN2-related disorder +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Leukoencephalopathy with mild cerebellar ataxia and white matter edema +3 more | GConflicting classifications of pathogenicity |
| | | Deletion (intron variant) | not provided | |